Table 2 Values (median and interquartile range) of inflammatory biomarkers and hemocytometry variables at different study timepoints.
From: Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study
Admission | 48 h | 96 h | Discharge | p | |
|---|---|---|---|---|---|
Leukocytes (cells/mL) | 8810 (6510–11,120) | 8360 (6255–10,790) | 7740 (6190–9595) | 7270 (5920–8940) | < 0.001 |
Neutrophils (cells/mL) | 6020 (4580–7990) | 5500 (3700–7780) | 4770 (3590–6440) | 4400 (3480–6000) | < 0.001 |
Lymphocytes (cells/mL) | 1395 (1028–1923) | 1700 (1240–2125) | 1695 (1388–2170) | 1940 (1488–2250) | < 0.001 |
Platelets (106 cells/mL) | 224 (174–270) | 225 (189–286) | 270 (205–328) | 289 (225–367) | < 0.001 |
NLR | 4.4 (3–5.7) | 3.2 (2.2–4.6) | 2.7 (2.1–4.2) | 2.7 (1.9–3.3) | < 0.001 |
Ferritin (µg/L) | 38.5 (21.5–64) | 44.8 (28.2–72.7) | 45.5 (31.2–78.5)) | 47.1 (30–76.2) | < 0.001 |
C reactive protein (mg/dL) | 1.66 (0.41–3.75) | 2 (0.7–4) | 1.3 (0.4–3.4) | 0.9 (0.3–2.1) | < 0.001 |
D-dimer (µg/L) | 1727 (1069–3328) | 1364 (980–2,171) | 1408 (982–1886) | 1439 (1029–1917) | 0.0248 |
Procalcitonin (µg/L) | 0.06 (0.045–0.1) | 0.06 (0.04–0.08) | 0.05 (0.03–0.07) | 0.04 (0.03–0.06) | < 0.001 |
Fibrinogen (mg/dL) | 474 (409–556) | 463 (387–543) | 469 (394–561) | 446 (375–525) | ns |
LDH (U/L) | 186 (155–236) | 189 (141–245) | 203 (154–264) | 166 (138–214) | ns |
AST (U/L) | 59 (41–107) | 55 (45–82) | 53 (42–72) | 45 (36–54) | 0.042 |
ALT (U/L) | 17 (13–24) | 19 (13–29) | 24 (15–40) | 24 (15–40) | < 0.001 |
